CIK 0001396814 · Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510619477
- Phone
- 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $288,539
- in 2 filings, $289K under 10b5-1 plans
Net −$288,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-30 | Cross Shawn Chief Financial Officer | Shares withheld for taxes | −9,540 | $36.39 | $347K | 95,801 |
| 2026-10-08 | RIKER LAUREN Senior Vice President, Finance | Option exercise 10b5-1 | +6,000 | $32.35 | $194K | 68,284.24 |
| 2026-10-08 | RIKER LAUREN Senior Vice President, Finance | Sale 10b5-1 | −6,000 | $36.32 | $218K | 62,284.24 |
| 2026-10-08 | RIKER LAUREN Senior Vice President, Finance | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,000 | 0 | ||
| 2026-08-17 | SLONIN JONATHAN Chief Medical Officer | Sale 10b5-1 | −3,040 | $23.23 | $71K | 216,383.65 |
| 2026-06-11 | RIKER LAUREN Senior Vice President, Finance | Sale 10b5-1 | −6,115 | $23.50 | $144K | 62,284.24 |
| 2026-06-10 | Hirawat Samit Director | Grant or award | +6,405 | 6,405 | ||
| 2026-06-10 | Hirawat Samit Director | Grant or award · Stock Option (Right to Buy) | +10,891 | 10,891 | ||
| 2026-06-10 | CHRISTIE CHRISTOPHER Director | Grant or award | +6,405 | 23,059 | ||
| 2026-06-10 | CHRISTIE CHRISTOPHER Director | Grant or award · Stock Option (Right to Buy) | +10,891 | 10,891 | ||
| 2026-06-10 | WIGGANS THOMAS G Director | Grant or award · Stock Option (Right to Buy) | +32,675 | 32,675 | ||
| 2026-06-10 | Young Alethia Director | Grant or award | +6,405 | 17,798 | ||
| 2026-06-10 | Young Alethia Director | Grant or award · Stock Option (Right to Buy) | +10,891 | 10,891 | ||
| 2026-06-10 | YANG MICHAEL J. Director | Grant or award | +6,405 | 19,798 | ||
| 2026-06-10 | YANG MICHAEL J. Director | Grant or award · Stock Option (Right to Buy) | +10,891 | 10,891 | ||
| 2026-06-10 | BIGAL MARCELO Director | Grant or award | +6,405 | 17,798 | ||
| 2026-06-10 | BIGAL MARCELO Director | Grant or award · Stock Option (Right to Buy) | +10,891 | 10,891 | ||
| 2026-06-10 | Froimson Mark Director | Grant or award | +6,405 | 26,541 | ||
| 2026-06-10 | Froimson Mark Director | Grant or award · Stock Option (Right to Buy) | +10,891 | 10,891 | ||
| 2026-06-10 | Brege Laura Director | Grant or award | +6,405 | 30,120 |
Page 1 of 9 · 161 trades